ArticleFrontiers in immunology2019

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.

Mona O Mohsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.